Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedRevision updated to v3.5.2; prior Revision v3.5.0 was removed.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page shows new update dates in April 2026 (April 6–7) and removes March 2026 entries, reflecting administrative record-keeping updates.SummaryDifference0.1%

- Check16 days agoChange DetectedAn Actual entry for 2026-04-01 was added to the update history and an Estimated entry for 2026-03-16 was removed.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded 'Squamous cell carcinoma of the head and neck' to the study's conditions/keywords and included 'Genetic and Rare Diseases Information Center' as a resources entry.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Northwestern University in Evanston, IL and Naples, Italy as study locations. The total location count is updated to 173 and Napoli is standardized to Naples, with a page revision to v3.5.0.SummaryDifference0.2%

- Check44 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.